Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Overactive Bladder |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | August 2015 |
| End Date: | July 2016 |
This study is a retrospective chart review of patients treated with BOTOX® for idiopathic
Overactive Bladder (OAB) as standard of care in clinical practice. The study will determine
the rate of post procedural urinary retention requiring catheterization and identify factors
that may predict urinary retention.
Overactive Bladder (OAB) as standard of care in clinical practice. The study will determine
the rate of post procedural urinary retention requiring catheterization and identify factors
that may predict urinary retention.
Inclusion Criteria:
-Patients treated with BOTOX® for Overactive Bladder.
Exclusion Criteria:
- Received botulinum toxin formulations other than BOTOX® in the bladder.
- Had symptoms of OAB associated with a neurological condition.
- Had a history of chronic urinary retention treated with Clean Intermittent
Catheterization (CIC) or indwelling catheter.
We found this trial at
7
sites
Charlotte, North Carolina 28203
Click here to add this to my saved trials
MetroHealth Med Ctr The MetroHealth System is one of the largest, most comprehensive health care...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Winston-Salem, North Carolina 27103
Click here to add this to my saved trials